Date published: 2025-10-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC729991 Activators

The discovery of LOC729991 activators would begin with the elucidation of the properties and biological role of the encoded protein, should it exist. This would involve a combination of genomic, proteomic, and biochemical techniques to determine its expression pattern, cellular localization, and functional interactions. If the protein were to play a role in a particular cellular pathway, understanding the mechanism of action would be crucial. Structural biologists might use techniques such as X-ray crystallography or cryo-electron microscopy to resolve the protein's structure, which would reveal potential binding sites for small molecules. Such structural insights would be invaluable for the rational design of molecules that could interact with the protein and modulate its activity.

Once target sites on the protein are identified, chemical libraries could be screened for molecules that interact with those sites. Hits from these screens would represent initial activator candidates, which would then be subject to further chemical optimization. This process would involve synthesizing derivatives of the initial molecules, tweaking their chemical structures to improve their binding efficiency, selectivity for LOC729991, and cellular uptake. Such optimization is a meticulous, iterative process that relies heavily on structure-activity relationship (SAR) studies, where each modification to the molecular structure is evaluated for its impact on the interaction with LOC729991. The development of LOC729991 activators would provide important tools for probing the function of the protein and could potentially illuminate new aspects of cellular function, contributing to the basic understanding of cellular biology and expanding the compendium of molecular tools available for research.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Tretinoin, a retinoic acid receptor agonist, can modulate gene transcription and might induce the readthrough expression in specific cell types.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA activates protein kinase C (PKC), which can lead to altered transcription factor activity and gene expression.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$27.00
$37.00
5
(0)

As a beta-adrenergic agonist, isoproterenol can increase cAMP levels, potentially affecting gene transcription through the cAMP response element-binding protein (CREB).

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$94.00
$349.00
114
(2)

Thapsigargin raises intracellular calcium levels, which can modulate calcium-sensitive signaling pathways influencing gene expression.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Camptothecin inhibits topoisomerase I, affecting DNA replication and transcription, which could influence readthrough transcription events.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$60.00
$270.00
$350.00
48
(2)

AICAR activates AMPK, which can regulate transcriptional programs involved in cellular stress responses and potentially readthrough expression.

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

SB431542 is an inhibitor of the TGF-beta receptor, affecting downstream signaling and potentially altering transcriptional readthrough.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor that can alter AKT signaling and downstream transcriptional activities, possibly affecting readthrough expression.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin inhibits mTOR signaling, which could lead to changes in gene transcription and possibly influence readthrough events.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

SAHA is a histone deacetylase inhibitor that alters chromatin structure and can affect gene expression, potentially inducing readthrough.